| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.661 | 1.120 | 3.797 | 4.892 | 31.764 | 70.115 | 24.058 | 27.770 | 19.046 |
| Total Income - EUR | - | 2.661 | 1.120 | 3.797 | 4.892 | 31.764 | 70.115 | 24.058 | 27.770 | 19.046 |
| Total Expenses - EUR | - | 3.634 | 4.519 | 9.327 | 10.957 | 14.690 | 37.957 | 18.537 | 13.982 | 13.568 |
| Gross Profit/Loss - EUR | - | -973 | -3.399 | -5.530 | -6.065 | 17.073 | 32.157 | 5.522 | 13.788 | 5.478 |
| Net Profit/Loss - EUR | - | -1.000 | -3.410 | -5.568 | -6.114 | 16.770 | 31.540 | 5.317 | 13.523 | 5.314 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bimka Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 597 | 5.131 | 4.185 | 3.407 |
| Current Assets | - | 462 | 218 | 2.035 | 574 | 4.089 | 35.214 | 11.430 | 25.572 | 31.565 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 23.407 | 324 | 16.475 | 21.322 |
| Cash | - | 462 | 218 | 2.035 | 574 | 4.089 | 11.807 | 11.106 | 9.098 | 10.244 |
| Shareholders Funds | - | -955 | -4.349 | -9.838 | -15.761 | 1.308 | 32.819 | 14.758 | 28.236 | 33.393 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.418 | 4.567 | 11.873 | 16.335 | 2.782 | 2.993 | 1.802 | 1.554 | 1.580 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Bimka Bio S.r.l.